RTSM Resources

  1. RTSM System Customizability Drives Personalized Medicine Trials 1/29/2025

    eClinical experts discuss supply chain management and IRT system design in clinical trials that include personalized medicine elements.

  2. eClinical Platform Accelerates COVID-19 Treatment Trial By 2 Weeks 1/8/2024

    Examine a COVID-19 treatment trial that utilized integrated EDC, eConsent, eCOA, RTSM, and TeleVisit solutions, all within a single platform, to address three critical challenges.

  3. How Clinical Trial Complexity Impacts End Users 11/11/2022

    This article examines clinical trial complexity through the lens of study investigators, site staff, CRAs, sponsor study and supply managers, and how the RTSM/ IRT provides the ability to be as creative as needed.

  4. Best Practices For Changing From One eClinical Vendor To Another 10/24/2023

    Switching solution providers mid-study isn't uncommon. But how can teams avoid schedule delays, interrupted operations, and errors? Learn best practices from this example by Signant Biotech.

  5. What Is Agile RTSM, Really? 1/18/2022

    Recently, there has been a lot of messaging around agility in Randomization and Trial Supply Management (RTSM) or as some refer to it, Interactive Response Technology (IRT). Is “agile” becoming the new “innovative”? Find out more in this white paper.

  6. The Crucial Role Of IRT/RTSM In Optimizing Drug Supply Budgets 10/4/2024

    Expand your knowledge of IRT/RTSM systems and their capabilities to tailor supplies to site-specific recruitment, significantly decrease drug waste and costs, ensure efficient IMP management, and more.

  7. RTSM And IRT Solutions For Clinical Trials 12/10/2025

    Global leader in RTSM/IRT, helping sponsors and CROs speed study start-up, optimize supply, and manage complex trials with confidence.

  8. Driving Customer Profitability With Enterprise Platform, Pricing 2/29/2024

    Explore how the solutions and approaches offered by CDS can help different research stakeholders conduct more cost-efficient clinical trials in the industry's pharmaceutical, biotech, and device sectors.